326 related articles for article (PubMed ID: 25070582)
1. Use of Factor XIII (FXIII) concentrate in patients with congenital FXIII deficiency undergoing surgical procedures.
Janbain M; Nugent DJ; Powell JS; St-Louis J; Frame VB; Leissinger CA
Transfusion; 2015 Jan; 55(1):45-50. PubMed ID: 25070582
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of prophylactic treatment with plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency.
Ashley C; Chang E; Davis J; Mangione A; Frame V; Nugent DJ
Haemophilia; 2015 Jan; 21(1):102-8. PubMed ID: 25377187
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and safety of plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency.
Nugent DJ; Ashley C; García-Talavera J; Lo LC; Mehdi AS; Mangione A
Haemophilia; 2015 Jan; 21(1):95-101. PubMed ID: 25458735
[TBL] [Abstract][Full Text] [Related]
4. A large case series on surgical outcomes in congenital factor XIII deficiency patients in Iran.
Naderi M; Haghpanah S; Miri-Aliabad G; Tavosi H; Karimi M
J Thromb Haemost; 2017 Dec; 15(12):2300-2305. PubMed ID: 29028293
[TBL] [Abstract][Full Text] [Related]
5. [Congenital factor XIII deficiency required high-dose factor XIII concentrate in late pregnancy].
Takahashi T; Hatao K; Suzukawa M; Oji T
Rinsho Ketsueki; 2007 May; 48(5):418-20. PubMed ID: 17571589
[TBL] [Abstract][Full Text] [Related]
6. Corifact™/Fibrogammin® P in the prophylactic treatment of hereditary factor XIII deficiency: results of a prospective, multicenter, open-label study.
Nugent D
Thromb Res; 2012 Dec; 130 Suppl 2():S12-4. PubMed ID: 23439001
[TBL] [Abstract][Full Text] [Related]
7. Biology of Factor XIII and clinical manifestations of Factor XIII deficiency.
Levy JH; Greenberg C
Transfusion; 2013 May; 53(5):1120-31. PubMed ID: 22928875
[TBL] [Abstract][Full Text] [Related]
8. Factor XIII deficiency enhances thrombin generation due to impaired fibrin polymerization - An effect corrected by Factor XIII replacement.
Pitkänen HH; Jouppila A; Lemponen M; Ilmakunnas M; Ahonen J; Lassila R
Thromb Res; 2017 Jan; 149():56-61. PubMed ID: 27902939
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: a randomized, placebo-controlled, multicenter clinical trial.
Karkouti K; von Heymann C; Jespersen CM; Korte W; Levy JH; Ranucci M; Sellke FW; Song HK
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):927-39. PubMed ID: 23820174
[TBL] [Abstract][Full Text] [Related]
10. [Factor XIII deficiency - not only a congenital bleeding disorder].
Schött U; Astermark J; Zdanowski A; Strandberg K
Lakartidningen; 2023 Apr; 120():. PubMed ID: 37099358
[TBL] [Abstract][Full Text] [Related]
11. Long-term prophylaxis in patients with severe congenital factor XIII deficiency is not complicated by inhibitor formation.
Naderi M; Ahmadinejad M; Hosseini MS; Moradi E; Dorgalaleh A; Shamsizadeh M
Blood Coagul Fibrinolysis; 2017 Jun; 28(4):276-278. PubMed ID: 27306330
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous epidural hematoma in a child with inherited factor XIII deficiency.
Farah RA; Al Danaf JZ; Chahinian RA; Braiteh NT; Al Ojaimi NF; Cairo A; Farhat H; Mantoura JR
J Pediatr Hematol Oncol; 2014 Jan; 36(1):62-5. PubMed ID: 23619114
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and tolerability of factor XIII concentrates prepared from human placenta or plasma: a crossover randomised study.
Brackmann HH; Egbring R; Ferster A; Fondu P; Girardel JM; Kreuz W; Masure R; Miloszewski K; Stibbe J; Zimmermann R
Thromb Haemost; 1995 Aug; 74(2):622-5. PubMed ID: 8584996
[TBL] [Abstract][Full Text] [Related]
14. Clinical influence of preoperative factor XIII activity in patients undergoing pancreatoduodenectomy.
Watanabe N; Yokoyama Y; Ebata T; Sugawara G; Igami T; Mizuno T; Yamaguchi J; Nagino M
HPB (Oxford); 2017 Nov; 19(11):972-977. PubMed ID: 28728890
[TBL] [Abstract][Full Text] [Related]
15. Factor XIII: congenital deficiency factor XIII, acquired deficiency, factor XIII A-subunit, and factor XIII B-subunit.
Tahlan A; Ahluwalia J
Arch Pathol Lab Med; 2014 Feb; 138(2):278-81. PubMed ID: 24476525
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of recombinant factor XIII in young children with congenital FXIII deficiency and comparison with older patients.
Williams M; Will A; Stenmo C; Rosholm A; Tehranchi R
Haemophilia; 2014 Jan; 20(1):99-105. PubMed ID: 23834599
[TBL] [Abstract][Full Text] [Related]
17. Minimal factor XIII activity level to prevent major spontaneous bleeds.
Menegatti M; Palla R; Boscarino M; Bucciarelli P; Muszbek L; Katona E; Makris M; Peyvandi F;
J Thromb Haemost; 2017 Sep; 15(9):1728-1736. PubMed ID: 28688221
[TBL] [Abstract][Full Text] [Related]
18. [Factor XIII : Pharmacodynamic and pharmacokinetic characteristics].
Adam EH; Kreuer S; Zacharowski K; Weber CF; Wildenauer R
Anaesthesist; 2017 Jan; 66(1):52-59. PubMed ID: 27942785
[TBL] [Abstract][Full Text] [Related]
19. Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions.
Dickneite G; Herwald H; Korte W; Allanore Y; Denton CP; Matucci Cerinic M
Thromb Haemost; 2015 Apr; 113(4):686-97. PubMed ID: 25652913
[TBL] [Abstract][Full Text] [Related]
20. Successful Management of a Patient with Autoimmune Hemorrhaphilia due to Anti-Factor XIII/13 Antibodies Complicated by Pulmonary Thromboembolism.
Ogawa Y; Yanagisawa K; Souri M; Mihara M; Naito C; Takizawa M; Ishizaki T; Mitsui T; Handa H; Osaki T; Nojima Y; Ichinose A
Acta Haematol; 2017; 137(3):141-147. PubMed ID: 28380473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
